// App-Quantinova.ai

e23181 : Detection of actionable genome alterations using hybrid capture based next generation sequencing technology: NEOplus and NEOliquid.

Researchers

Presenter

  • Lukas C. Heukamp

Principal Investigators

  • Roopika Menon

  • Judith Mueller

  • Sotirios Lakis

  • Johannes Schulte

  • Gunther Wiest

  • Frank Griesinger

  • Christoph Salat

  • Rafal Dziadziuszko

  • Oliver Gautschi

  • Christian Grohe

  • John Crown

  • Johannes Heuckmann

Medical Centers

  • NEO New Oncology AG, Cologne, Germany

  • Paediatric Oncology and Hematology Charite, University Hospital Berlin, Berlin, Germany

  • Asklepios Clinic Harburg, Harburg, Germany

  • Pius-Hospital Oldenburg, University of Oldenburg, Oldenburg, Germany

  • Hematology - Oncology Clinic, Munich, Germany

  • Medical University of Gdansk, Gdansk, Poland

  • Cantonal Hospital Lucerne and Swiss Group for Clinical Cancer Research (SAKK), Luzern, Switzerland

  • Pneumologia Evangelische Lungenklinik, Berlin, Germany

  • Irish Cooperative Oncology Research Group, Dublin, Ireland

Locations

  • Poland

  • Germany

  • Ireland

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved